Current management and long-term outcomes following chorioamnionitis

Obstetrics and Gynecology Clinics of North America

Volumn 41, Issue 4, 2014, Pages 649-669

  Johnson, Clark T ^a   Farzin, Azadeh ^a,b   Burd, Irina ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chorioamnionitis; Endometritis; Fetal infection; Fetal inflammation; Funisitis; Neonatal sepsis; Perinatal infection; Perinatal inflammation

Indexed keywords

AMPICILLIN; BETAMETHASONE; CEPHALOSPORIN; CLINDAMYCIN; GENTAMICIN; MACROLIDE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

AMNION FLUID ANALYSIS; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; CESAREAN SECTION; CHORIOAMNIONITIS; CLINICAL ASSESSMENT; COMBINATION CHEMOTHERAPY; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; ESCHERICHIA COLI INFECTION; FETUS OUTCOME; GRAM NEGATIVE INFECTION; GROUP B STREPTOCOCCAL INFECTION; HISTOPATHOLOGY; HUMAN; INCIDENCE; INFECTION RISK; LISTERIA MONOCYTOGENES; MATERNAL MORBIDITY; MONOTHERAPY; NEWBORN CARE; NEWBORN MORBIDITY; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; PREVALENCE; REVIEW; SCREENING; STEROID THERAPY; SYMPTOMATOLOGY; ADULT; AMNION FLUID; DELIVERY; DRUG ADMINISTRATION; EARLY DIAGNOSIS; FEMALE; MICROBIOLOGY; NEWBORN; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTOR; SEPSIS; TREATMENT OUTCOME; UNITED STATES;

ADULT; AMNIOTIC FLUID; ANTI-BACTERIAL AGENTS; CHORIOAMNIONITIS; DELIVERY, OBSTETRIC; DRUG ADMINISTRATION SCHEDULE; EARLY DIAGNOSIS; FEMALE; HUMANS; INFANT, NEWBORN; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; SEPSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84912125435     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2014.08.007     Document Type: Review

References (71)

1. Kim M.J., Romero R., Gervasi M.T., et al. Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-amniotic infection. Lab Invest 2009, 89(8):924-936.
2. Keski-Nisula L., Kirkinen P., Katila M.L., et al. Cesarean delivery. Microbial colonization in amniotic fluid. JReprod Med 1997, 42(2):91-98.
3. Combs C.A., Gravett M., Garite T.J., et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014, 210(2):125.e1-125.e15. ProteoGenix/Obstetrix Collaborative Research Network.
4. Schrag S.J., Verani J.R. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine 2013, 31(Suppl 4):D20-D26.
5. Curtin W.M., Katzman P.J., Florescue H., et al. Accuracy of signs of clinical chorioamnionitis in the term parturient. JPerinatol 2013, 33(6):422-428.
6. Fusi L., Steer P.J., Maresh M.J., et al. Maternal pyrexia associated with the use of epidural analgesia in labour. Lancet 1989, 1(8649):1250-1252.
7. Abramovici A., Szychowski J.M., Biggio J.R., et al. Epidural use and clinical chorioamnionitis among women who delivered vaginally. Am J Perinatol 2014, [Epub ahead of print].
8. Le Doare K., Heath P.T. An overview of global GBS epidemiology. Vaccine 2013, 31(Suppl 4):D7-D12.
9. Tita A.T., Andrews W.W. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 2010, 37(2):339-354.
10. Hoang D., Charlagorla P., Salafia C., et al. Histologic chorioamnionitis as a consideration in the management of newborns of febrile mothers. JMatern Fetal Neonatal Med 2013, 26(8):828-832.
11. Torricelli M., Voltolini C., Conti N., et al. Histologic chorioamnionitis at term: implications for the progress of labor and neonatal wellbeing. JMatern Fetal Neonatal Med 2013, 26(2):188-192.
12. Sun C.C., Revell V.O., Belli A.J., et al. Discrepancy in pathologic diagnosis of placental lesions. Arch Pathol Lab Med 2002, 126(6):706-709.
13. Mi Lee S., Romero R., Lee K.A., et al. The frequency and risk factors of funisitis and histologic chorioamnionitis in pregnant women at term who delivered after the spontaneous onset of labor. JMatern Fetal Neonatal Med 2011, 24(1):37-42.
14. Nath C.A., Ananth C.V., Smulian J.C., New Jersey-Placental Abruption Study Investigators, et al. Histologic evidence of inflammation and risk of placental abruption. Am J Obstet Gynecol 2007, 197(3):319.e1-319.e6.
15. Roberts D.J., Celi A.C., Riley L.E., et al. Acute histologic chorioamnionitis at term: nearly always noninfectious. PLoS One 2012, 7(3):e318-e319.
16. Kallapur S.G., Presicce P., Rueda C.M., et al. Fetal immune response to chorioamnionitis. Semin Reprod Med 2014, 32(1):56-67.
17. Burd I., Balakrishnan B., Kannan S. Models of fetal brain injury, intrauterine inflammation, and preterm birth. Am J Reprod Immunol 2012, 67(4):287-294.
18. Dada T., Rosenzweig J.M., Al Shammary M., et al. Mouse model of intrauterine inflammation: sex-specific differences in long-term neurologic and immune sequelae. Brain Behav Immun 2014, 38:142-150.
19. Kannan S., Dai H., Navath R.S., et al. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med 2012, 4(130):130-146.
20. Rouse D.J., Landon M., Leveno K.J., National Institute of Child Health And Human Development, Maternal-Fetal Medicine Units Network, et al. The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes. Am J Obstet Gynecol 2004, 191:211-216.
21. Salas A.A., Faye-Petersen O.M., Sims B., et al. Histological characteristics of the fetal inflammatory response associated with neurodevelopmental impairment and death in extremely preterm infants. JPediatr 2013, 652:7.e1-7.e2.
22. van Vliet E.O., de Kieviet J.F., van der Voorn J.P., et al. Placental pathology and long-term neurodevelopment of very preterm infants. Am J Obstet Gynecol 2012, 206(6):489.e1-489.e7.
23. Suppiej A., Franzoi M., Vedovato S., et al. Neurodevelopmental outcome in preterm histological chorioamnionitis. Early Hum Dev 2009, 85(3):187-189.
24. Soraisham A.S., Trevenen C., Wood S., et al. Histological chorioamnionitis and neurodevelopmental outcome in preterm infants. JPerinatol 2013, 33(1):70-75.
25. Rovira N., Alarcon A., Iriondo M., et al. Impact of histological chorioamnionitis, funisitis and clinical chorioamnionitis on neurodevelopmental outcome of preterm infants. Early Hum Dev 2011, 87(4):253-257.
26. Perrone S., Toti P., Toti M.S., et al. Perinatal outcome and placental histological characteristics: a single-center study. JMatern Fetal Neonatal Med 2012, 25(Suppl 1):110-113.
27. Shatrov J.G., Birch S.C., Lam L.T., et al. Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol 2010, 116(2 Pt 1):387-392. [meta-analysis].
28. García-Muñoz Rodrigo F., Galán Henríquez G.M., Ospina C.G. Morbidity and mortality among very-low-birth-weight infants born to mothers with clinical chorioamnionitis. Pediatr Neonatol 2014, 10.1016/j.pedneo.2013.12.007.
29. Alexander J.M., Gilstrap L.C., Cox S.M., et al. Clinical chorioamnionitis and the prognosis for very low birth weight infants. Obstet Gynecol 1998, 91(5 Pt 1):725-729.
30. Wu Y.W., Colford J.M. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000, 284(11):1417-1424. [meta-analysis].
31. Strunk T., Doherty D., Jacques A., et al. Histologic chorioamnionitis is associated with reduced risk of late-onset sepsis in preterm infants. Pediatrics 2012, 129(1):e134-e141.
32. Been J.V., Lievense S., Zimmermann L.J., et al. Chorioamnionitis as a risk factor for necrotizing enterocolitis: a systematic review and meta-analysis. JPediatr 2013, 162(2):236-242.e2. [meta-analysis].
33. Hartling L., Liang Y., Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2012, 97(1):F8-F17. [meta-analysis].
34. Mitra S., Aune D., Speer C.P., et al. Chorioamnionitis as a risk factor for retinopathy of prematurity: a systematic review and meta-analysis. Neonatology 2014, 105(3):189-199. [meta-analysis].
35. Pappas A., Kendrick D.E., Shankaran S., et al. Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr 2014, 168(2):137-147.
36. Nabhan A.F., Elhelaly A., Elkadi M. Antibiotic prophylaxis in prelabor spontaneous rupture of fetal membranes at or beyond 36 weeks of pregnancy. Int J Gynaecol Obstet 2014, 124(1):59-62.
37. Ovalle A., Romero R., Gómez R., et al. Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation?. JMatern Fetal Neonatal Med 2006, 19(8):453-464.
38. Hutzal C.E., Boyle E.M., Kenyon S.L., et al. Use of antibiotics for the treatment of preterm parturition and prevention of neonatal morbidity: a meta-analysis. Am J Obstet Gynecol 2008, 199(6):620.e1-620.e8. [meta-analysis].
39. ACOG (American Congress of Obstetricians and Gynecologists) Committee on Practice Bulletins-Obstetrics ACOG practice bulletin No. 120: use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2011, 117(6):1472-1483.
40. Didier C., Streicher M.P., Chognot D., et al. Late-onset neonatal infections: incidences and pathogens in the era of antenatal antibiotics. Eur J Pediatr 2012, 171(4):681-687.
41. Bizzarro M.J., Dembry L.M., Baltimore R.S., et al. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics 2008, 121(4):689-696.
42. Shah P., Nathan E., Doherty D., et al. Prolonged exposure to antibiotics and its associations in extremely preterm neonates-the Western Australian experience. JMatern Fetal Neonatal Med 2013, 26(17):1710-1714.
43. Gomez R., Romero R., Nien J.K., et al. Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection. JMatern Fetal Neonatal Med 2007, 20(2):167-173.
44. Goldenberg R.L., Mwatha A., Read J.S., et al. The HPTN 024 study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol 2006, 194(3):650-661.
45. Hopkins L., Smaill F. Antibiotic regimens for management of intraamniotic infection. Cochrane Database Syst Rev 2002, (3). [meta-analysis], CD003254.
46. Ugwumadu A., Reid F., Hay P., et al. Oral clindamycin and histologic chorioamnionitis in women with abnormal vaginal flora. Obstet Gynecol 2006, 107(4):863-868.
47. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001, 357(9261):979-988. ORACLE Collaborative Group.
48. Kenyon S., Boulvain M., Neilson J.P. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2013, (12). [meta-analysis], CD001058.
49. American ACOG (American Congress of Obstetricians and Gynecologists) Committee on Obstetric Practice ACOG committee opinion No. 485: prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol 2011, 117(4):1019-1027.
50. Verani J.R., McGee L., Schrag S.J., Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Morb Mortal Wkly Rep 2010, 59(RR-10):1-36.
51. Verani J.R., Spina N.L., Lynfield R., et al. Early-onset group B streptococcal disease in the united states: potential for further reduction. Obstet Gynecol 2014, 123(4):828-837.
52. Greenberg M.B., Anderson B.L., Schulkin J., et al. Afirst look at chorioamnionitis management practice variation among US obstetricians. Infect Dis Obstet Gynecol 2012, 2012:628362.
53. Czikk M.J., McCarthy F.P., Murphy K.E. Chorioamnionitis: from pathogenesis to treatment. Clin Microbiol Infect 2011, 17(9):1304-1311.
54. Gonçalves L.F., Chaiworapongsa T., Romero R. Intrauterine infection and prematurity. Ment Retard Dev Disabil Res Rev 2002, 8(1):3-13.
55. ACOG (American Congress of Obstetricians and Gynecologists) Committee on Practice Bulletins-Obstetrics ACOG practice bulletin No. 127: management of preterm labor. Obstet Gynecol 2012, 119(6):1308-1317.
56. Joram N., Launay E., Roze J.C., et al. Betamethasone worsens chorioamnionitis-related lung development impairment in rabbits. Am J Perinatol 2011, 28(8):605-612.
57. Been J.V., Degraeuwe P.L., Kramer B.W., Zimmermann L.J. Antenatal steroids and neonatal outcome after chorioamnionitis: a meta-analysis. BJOG 2011, 118(2):113-122. [meta-analysis].
58. Van Dyke M.K., Phares C.R., Lynfield R., et al. Evaluation of universal antenatal screening for group B streptococcus. NEngl J Med 2009, 360(25):2626-2636.
59. Kim S.Y., Russell L.B., Park J., et al. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa. Vaccine 2014, 32(17):1954-1963.
60. Bastek J.A., Weber A.L., McShea M.A., et al. Prenatal inflammation is associated with adverse neonatal outcomes. Am J Obstet Gynecol 2014, 210(5):450.e1-450.e10.
61. Horowitz S., Horowitz J., Mazor M., et al. Ureaplasma urealyticum cervical colonization as a marker for pregnancy complications. Int J Gynaecol Obstet 1995, 48(1):15-19.
62. Yoon B.H., Romero R., Lim J.H., et al. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003, 189(4):919-924.
63. Genc M.R., Ford C.E. The clinical use of inflammatory markers during pregnancy. Curr Opin Obstet Gynecol 2010, 22(2):116-121.
64. Baker C.J., Carey V.J., Rench M.A., et al. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. JInfect Dis 2014, 209(5):781-788.
65. Burns G., Plumb J. GBS public awareness, advocacy, and prevention-what's working, what's not and why we need a maternal GBS vaccine. Vaccine 2013, 31(Suppl 4):D58-D65.
66. Le Doare K., Kampmann B. Breast milk and group B streptococcal infection: vector of transmission or vehicle for protection?. Vaccine 2014, 32(26):3128-3132.
67. Dempsey A.F., Pyrzanowski J., Donnelly M., et al. Acceptability of a hypothetical group B strep vaccine among pregnant and recently delivered women. Vaccine 2014, 32(21):2463-2468.
68. Melin P., Efstratiou A. Group B streptococcal epidemiology and vaccine needs in developed countries. Vaccine 2013, 31(Suppl 4):D31-D42.
69. Menon R., Taylor R.N., Fortunato S.J. Chorioamnionitis-a complex pathophysiologic syndrome. Placenta 2010, 31(2):113-120.
70. Romero R., Miranda J., Chaiworapongsa T., et al. Anovel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes. Am J Reprod Immunol 2014, 71(4):330-358.
71. Oh K.J., Lee S.E., Jung H., et al. Detection of ureaplasmas by the polymerase chain reaction in the amniotic fluid of patients with cervical insufficiency. JPerinat Med 2010, 38(3):261-268.